| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/26/2009 | US20090081791 Intracellular delivery of small molecules, proteins, and nucleic acids |
| 03/26/2009 | US20090081780 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemagglutinin/esterase |
| 03/26/2009 | US20090081779 Tumor suppressor gene, p28ing5 |
| 03/26/2009 | US20090081764 Heterologous G protein coupled receptors expressed in yeast, their fusion with G proteins and use thereof in bioassay |
| 03/26/2009 | US20090081754 Gene of enzyme having activity to generate lachrymatory factor |
| 03/26/2009 | US20090081753 Method for formulating and immobilizing a matrix protein and a matrix protein for use in a sensor |
| 03/26/2009 | US20090081730 Activatable recombinant neurotoxins |
| 03/26/2009 | US20090081729 Compositions and Methods Comprising a Ligand of ChemerinR |
| 03/26/2009 | US20090081727 CD33-Like Protein |
| 03/26/2009 | US20090081725 Compositions of pamps and Listeria monocytogenes and methods of use |
| 03/26/2009 | US20090081724 identifying a subject predisposed to a disorder associated with ion channel dysfunction; epilepsy; isolated nucleic acid molecule encoding a mutant or variant ion channel subunit |
| 03/26/2009 | US20090081708 Methods and Compositions for Detection of Ehrlichia chaffeensis (VLPT) |
| 03/26/2009 | US20090081707 Human trk receptors and neurotrophic factor inhibitors |
| 03/26/2009 | US20090081705 Novel peptides and compositions which modulate apoptosis |
| 03/26/2009 | US20090081693 identifying an inhibitor of an agonist to receptors CCR2 and/or CCR5 (chemokine C-C motif receptor); signal transduction system in the G protein relating signal transduction in the CCL2-CCR2 pathway |
| 03/26/2009 | US20090081691 Transfecting a eukaryotic cell with nucleotide sequence, contacting cell with a candidate compound; determining distribution of expressed protein in cell by detecting the distribution of detectable moiety in cell; drug screening for their ability to interact with transmembrane proteins |
| 03/26/2009 | US20090081672 Testing by immunoassay for overexpression which is an indicator of breast cancer; relates to cDNA sequences from a region of amplification on chromosome 20 associated with disease. used in hybridization methods for the identification of chromosomal abnormalities |
| 03/26/2009 | US20090081667 Viral Variants With Altered Susceptibility To Nucleoside Analogs And Uses Thereof |
| 03/26/2009 | US20090081653 A nucleic acid regulating the expression of a gene responsive to insulin where the nucleic acid hybridizes under moderate stringency conditions to a hybridization probe; obesity; insulin-resistance syndrome; antidiabetic and -proliferative |
| 03/26/2009 | US20090081652 Constitutively Translocating Cell Line |
| 03/26/2009 | US20090081642 Novel apoptosis gene EI24, compositions, and methods of use |
| 03/26/2009 | US20090081637 Screening nucleic acid comprising sequence that encodes reverse transciptase domain of DNA polymerase for adefovir-resistant mutations; use in vaccine development |
| 03/26/2009 | US20090081298 Sustained release of apo a-i mimetic peptides and methods of treatment |
| 03/26/2009 | US20090081254 Hiv vaccine for mucosal delivery |
| 03/26/2009 | US20090081246 Method for isolating hepatitis c virus peptides |
| 03/26/2009 | US20090081243 Agents and methods for diagnosing stress |
| 03/26/2009 | US20090081237 Prognostic, diagnostic, and cancer therapeutic uses of FANCI and FANCI modulating agents |
| 03/26/2009 | US20090081236 Immunizing compositions and methods of use |
| 03/26/2009 | US20090081235 Pseudomonas exotoxin a-like chimeric immunogens for eliciting a secretory iga-mediated immune response |
| 03/26/2009 | US20090081232 Methods of treating diseases with anti-vegf antibodies |
| 03/26/2009 | US20090081230 Human cytomegalovirus neutralising antibodies and use thereof |
| 03/26/2009 | US20090081229 Anti-pro87299 antibodies |
| 03/26/2009 | US20090081228 Cyr61 compositions and methods |
| 03/26/2009 | US20090081227 Promotong differentiation of neural stem cells to nerve cells for use in treating injury to central nerve system caused by brain infarction, hemorrhage and/or spinal cord injury |
| 03/26/2009 | US20090081226 Soluble HLA-E Molecules And Their Use For Diagnosing And Treating Pathologies |
| 03/26/2009 | US20090081224 Compositions of polypeptides specific to pathogenic strains and their use as vaccines and in immunotheraphy |
| 03/26/2009 | US20090081217 Modified Chimeric Polypeptides with Improved Pharmacokinetic Properties |
| 03/26/2009 | US20090081215 Genetic products differentially expressed in tumors and use thereof |
| 03/26/2009 | US20090081214 Genetic products differentially expressed in tumors and use thereof |
| 03/26/2009 | US20090081209 Methods of therapy and diagnosis using targeting of cells that express killer cell immunoglobulin-like receptor-like proteins |
| 03/26/2009 | US20090081204 Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid beta for induction of an immune response to amyloid beta and amyloid deposits |
| 03/26/2009 | US20090081199 Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof |
| 03/26/2009 | US20090081193 Hemagglutinin polypeptides, and reagents and methods relating thereto |
| 03/26/2009 | US20090081181 Isolation of growth and differentiating factors from colostrum |
| 03/26/2009 | US20090081172 Nucleic acid encoding a receptor other than an immunoglobulin, wherein the receptor binds to a MUC 1 tumor antigen independently of a major histocompatibility complex (MHC); activating a signaling pathway and/or killing a cancer cell using a receptor that is similar to or is a T cell receptor |
| 03/26/2009 | US20090081168 Method of forming a peptide-receptor complex with zsig33 |
| 03/26/2009 | US20090081145 Process for forming disulphide bridges |
| 03/26/2009 | US20090081125 Angiogenetic Agent Containing Adrenomedulin as the Active Ingredient |
| 03/26/2009 | US20090081124 Virus coat protein/receptor chimeras and methods of use |
| 03/26/2009 | CA2711818A1 Method of reducing the effects of cytostatic drugs on bone marrow derived cells, and methods of screening |
| 03/26/2009 | CA2701871A1 Plants with increased yield |
| 03/26/2009 | CA2700476A1 Methods and compositions for detection of ehrlichia chaffeensis (vlpt) |
| 03/26/2009 | CA2700474A1 Methods and compositions for detection of ehrlichia chaffeensis (p120) |
| 03/26/2009 | CA2700265A1 Compositions and methods for altering the morphology of plants |
| 03/26/2009 | CA2700115A1 Long interspersed nuclear element polypeptide compositions and methods of use thereof |
| 03/26/2009 | CA2700047A1 Hypoallergenic variants of the major allergen from betula verrucosa pollen |
| 03/26/2009 | CA2699944A1 Targeted interferon demonstrates potent apoptotic and anti-tumor activities |
| 03/26/2009 | CA2699760A1 Compositions and methods for diagnosis and treatment of type 2 diabetes |
| 03/26/2009 | CA2698130A1 Modified xylan production |
| 03/26/2009 | CA2695467A1 Fhbp- and lpxl1-based vesicle vaccines for broad spectrum protection against diseases caused by neisseria meningitidis |
| 03/26/2009 | CA2694494A1 Hpiv-2 variants and medical applications thereof |
| 03/25/2009 | EP2040078A1 Method for quantifying phosphokinase activity on proteins |
| 03/25/2009 | EP2039773A1 Mutant vesicular stomatitis viruses and use thereof |
| 03/25/2009 | EP2039769A2 Antimicrobial peptides and methods of use |
| 03/25/2009 | EP2039768A1 Mutant forms of Fas ligand and uses thereof |
| 03/25/2009 | EP2039761A1 Influenza vaccine composition |
| 03/25/2009 | EP2039377A1 Rgd polypeptide grafted poly (glycolic acid-l-lysine-l-lactic acid) / -tricalcium phosphate composite material and preparation method thereof |
| 03/25/2009 | EP2038659A2 Method for identifying crmp modulators |
| 03/25/2009 | EP2038652A2 Method for detecting il-16 activity and modulation of il-16 activity based on rantes proxy levels |
| 03/25/2009 | EP2038423A2 A method of producing biologically active polypeptide having insulinotropic activity |
| 03/25/2009 | EP2038417A2 Compositions and methods for enhancing the efficacy of il-2 mediated immune responses |
| 03/25/2009 | EP2038415A1 Dph2 gene deletion mutant and uses thereof |
| 03/25/2009 | EP2038303A2 Crystal structure of ox40l and ox40l complexed with ox40 receptor |
| 03/25/2009 | EP2038302A2 Immunotoxins for the treatment of diseases related to cmv infection |
| 03/25/2009 | EP2038301A2 Compositions and methods for targeting cancer-specific transcription complexes |
| 03/25/2009 | EP2038300A2 High level antioxidant-containing foods |
| 03/25/2009 | EP2038299A2 Modified clostridial toxins with enhanced translocation capabilities and altered targeting activity for non-clostridial toxin target cells |
| 03/25/2009 | EP2038298A2 Modified clostridial toxins with enhanced translocation capabilities and altered targeting activity for clostridial toxin target cells |
| 03/25/2009 | EP2038297A1 Porphyromonas gingivalis polypeptides useful in the prevention of periodontal disease |
| 03/25/2009 | EP2037960A2 Methods for manipulating stem cells |
| 03/25/2009 | EP2037946A2 Phage derived antimicrobial activities |
| 03/25/2009 | EP2037737A2 Proteins, nucleic acids encoding the same and associated methods of use |
| 03/25/2009 | EP1882744A4 Method for producing an interleukin-2 preparation and the thus obtainable preparation |
| 03/25/2009 | EP1866333A4 Human cancer suppressor gene, protein encoded therein |
| 03/25/2009 | EP1846445B1 Pyy agonists and uses thereof |
| 03/25/2009 | EP1500704B1 Expression system of actinomycete-origin cytochrome p-450 in escherichia coli |
| 03/25/2009 | EP1499748B1 Hepatitis c virus assay systems |
| 03/25/2009 | EP1414288B1 Sugar and lipid metabolism regulators in plants iii |
| 03/25/2009 | EP1306383B1 Method of purifying a calcium ion-binding protein |
| 03/25/2009 | EP1141291B1 Method for the cellular high-throughput-detection of nuclear receptor ligand interactions |
| 03/25/2009 | EP0960197B1 GENES FROM 20q13 AMPLICON AND THEIR USES |
| 03/25/2009 | CN101395274A Chimeric Kunitz domains and their use |
| 03/25/2009 | CN101395180A Peptides useful as cell-penetrating peptides |
| 03/25/2009 | CN101395179A Peptides having activities of insulin like growth factor-1 and their uses |
| 03/25/2009 | CN101395178A Spider silk proteins and methods for producing spider silk proteins |
| 03/25/2009 | CN101395177A Expression control elements from the lemnaceae family |
| 03/25/2009 | CN101395176A Peptide sequences and compositions |
| 03/25/2009 | CN101395175A Chicken virus vaccine and diagnostic |
| 03/25/2009 | CN101395174A Hpv antigens, vaccine compositions, and related methods |
| 03/25/2009 | CN101395173A Template-fixed peptidomimetics with antimicrobial activity |